Our extensive database of Harvard technologies is available for new product development opportunities that will strengthen your strategic portfolio.

Available Technology

Monoclonal IgE anti-ovalbumin antibody



Technology:
Monoclonal Ig E mouse anti-ovalbumin

Markets Addressed


Currently there is no commercial IgE anti-ova available that could be useful as a positive control in ELISA assays which measure the level of IgE anti-ovalbumin antibodies in mouse models of asthma. Most investigators use a pool of positive serum as the positive control and express their results as an index. This reagent could be of interest to many asthma and immunology investigators.

Innovations and Advantages


A laboratory from the Harvard School of Public Health has developed a monoclonal Ig E mouse anti-ovalbumin. This antibody is useful as a positive control in ELISA assays used to measure the level of IgE anti-ovalbumin antibodies in mouse models of asthma. An IgG1 mouse anti-ovalbumin hybridoma is also available.

Additional Information


Publication:
-Characterization of this monoclonal was described in the article titled "Allergen-Independent Maternal Transmission of Asthma Susceptibility," Journal of Immunology, 2003, 170:1683-1689.



Inventor(s):
    Kobzik, Lester
    Palecanda, Aiyappa M.

Categories:
For further information, please contact:
Debra Peattie, Director of Business Development
(617) 495-3067
Reference Harvard Case #2203